RC

Roshantha A. Chandraratna

IT Io Therapeutics: 13 patents #1 of 13Top 8%
The Johns Hopkins University: 1 patents #91 of 501Top 20%
DC Dartmouth College: 1 patents #14 of 83Top 20%
📍 San Juan Capistrano, CA: #2 of 51 inventorsTop 4%
🗺 California: #733 of 66,859 inventorsTop 2%
Overall (2021): #4,582 of 548,734Top 1%
13
Patents 2021

Issued Patents 2021

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
11166927 Autoimmune disorder treatment using RXR agonists Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle 2021-11-09
11065219 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-07-20
10987330 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-04-27
10980760 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-04-20
10980759 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-04-20
10980761 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-04-20
10973791 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-04-13
10973788 Treatment of cancer with specific RXR agonists 2021-04-13
10946001 Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-03-16
10945976 Autoimmune disorder treatment using RXR agonists Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle 2021-03-16
10940127 Use of CYP26-resistant RAR alpha selective agonists in the treatment of cancer Gabriel Ghiaur, Richard J. Jones, Alonso Salvador 2021-03-09
10919835 Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids Vidyasagar Vuligonda, Thomas Jacks, Peter C. Wade, Andrew Thompson 2021-02-16
10881628 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Martin E. Sanders 2021-01-05